Regulatory workshop on standardisation of clinical procedures, endpoints and data robustness of human challenge studies - A stakeholder meeting report.
Meln I. et al, (2025), Biologicals, 90
Iberdomide increases innate and adaptive immune cell subsets in the bone marrow of patients with relapsed/refractory multiple myeloma.
Van Oekelen O. et al, (2024), Cell Rep Med, 5
Connecting single-nucleotide polymorphisms, glycosylation status, and interactions of plasma serine protease inhibitors.
Wu D. et al, (2023), Chem, 9, 665 - 681
Prolyl-tRNA synthetase as a novel therapeutic target in multiple myeloma.
Kurata K. et al, (2023), Blood Cancer J, 13
Cereblon pathway biomarkers and immune profiles in patients with myeloma receiving post-ASCT lenalidomide maintenance (LEOPARD).
Kalff A. et al, (2021), Leuk Lymphoma, 62, 2981 - 2991
VgrG and PAAR Proteins Define Distinct Versions of a Functional Type VI Secretion System.
Cianfanelli FR. et al, (2016), PLoS pathogens, 12
High-resolution quantitative proteome analysis reveals substantial differences between phagosomes of RAW 264.7 and bone marrow derived macrophages.
Guo M. et al, (2015), Proteomics, 15, 3169 - 3174
Quantitative proteome analysis of temporally resolved phagosomes following uptake via key phagocytic receptors.
Dill BD. et al, (2015), Mol Cell Proteomics, 14, 1334 - 1349
A holin and an endopeptidase are essential for chitinolytic protein secretion in Serratia marcescens.
Hamilton JJ. et al, (2014), J Cell Biol, 207, 615 - 626
Proteomic identification of novel secreted antibacterial toxins of the Serratia marcescens type VI secretion system.
Fritsch MJ. et al, (2013), Mol Cell Proteomics, 12, 2735 - 2749
Dissecting transcription regulatory pathways through a new bacterial one-hybrid reporter system.
Guo M. et al, (2009), Genome Res, 19, 1301 - 1308